Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
65.41
-1.05 (-1.58%)
At close: Oct 2, 2025
-1.58%
Market Cap11.04B
Revenue (ttm)8.82B
Net Income (ttm)1.14B
Shares Out168.76M
EPS (ttm)7.65
PE Ratio8.56
Forward PE8.62
Dividend1.50 (2.29%)
Ex-Dividend DateApr 22, 2025
Volume574,073
Average Volume1,029,028
Open66.46
Previous Close66.46
Day's Range65.30 - 66.95
52-Week Range43.50 - 69.36
Beta0.37
RSI59.68
Earnings DateNov 13, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.